This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5 High-Volume Movers to Watch

Onyx Pharmaceuticals

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Onyx Pharmaceuticals (ONXX) is a biopharmaceutical company engaged in developing therapies that target the molecular mechanisms that cause cancer.

Yesterday's Volume: 4,073,900

Average Volume: 1,278,280

Volume % Change: 211%

This stock added yesterday to its large gains from Monday of 14% as shares continue to attract buyers off optimism the company may be sold. A Bloomberg article mentioned that two people with knowledge of the matter said that the company is exploring options including a possible sale.

From a technical standpoint , this stock is running into some big overhead resistance at $45.90 to $46.07, where the sellers are overwhelming the buyers.

Despite the strong moves in this stock the last two trading sessions, I would not get interested from the long side until it can manage to take those resistance levels out with volume. This feels more like a case of sell-the-rumor than buy-the-rumor since the stock ran right into resistance.

I would only change my mind if ONXX can manage to sustain a high-volume move and close above $46.07 in the near future.
3 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
ONXX $0.00 0.00%
ECYT $3.79 -2.80%
GOLD $95.96 -3.70%
AAPL $94.63 1.10%
FB $117.77 -0.67%


Chart of I:DJI
DOW 17,719.20 -171.96 -0.96%
S&P 500 2,059.02 -22.41 -1.08%
NASDAQ 4,758.6670 -58.9270 -1.22%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs